The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Neglected Tropical Diseases Continue To Plague South Asia Despite Economic Growth
A new report showcases the disproportionately high burden of neglected tropical diseases in India and South Asia that continue to plague the 1.5 billion people living in the region.
Academia Sinica’s Dr. Li-Huei Tsai Elected To The US Institute Of Medicine
Dr. Li-Huei Tsai of Taiwan's Academia Sinica has been elected a member of the US Institute of Medicine.
Presenting Danica May Camacho Of Manila, Philippines… The World’s 7 Billionth Baby
Baby Danica May Camacho of the Philippines has been chosen by the United Nations as the symbolic seven billionth baby to be born worldwide.
Researchers Visualize Retinoic Acid Gradient In Live Embryo
Researchers in Japan have developed a new technique that enabled them to visualize the distribution of retinoic acid in a live zebrafish embryo, in real-time.
Sing-Song Cantonese Language Helps Musicality, Study
Non-musicians who speak tonal languages such as Cantonese may have a better ear for learning musical notes, says a new study.
How Do We Feed India’s Population In 2050?
The average Indian consumes only 2,300 calories per day - below the poverty level of 2,400 calories a day. The trend in recent years is for Indians to eat even less, writes Ranjit Goswami.
China To Launch Earth Observation Satellite This Month
China is planning to launch a high-resolution Earth observation satellite this month.
Chief Scientist Releases Plan For Australia’s Research
Chief Scientist Ian Chubb has launched the National Research Investment Plan, which sets new guidelines for Australian research investment.
Adaptive Licensing To Speed Up Drug Approvals In Singapore
Singapore's health regulatory agency is implementing a new drug development regulatory model to accelerate the translation of drugs into the clinic.